GARIAZZO, ELEONORA
 Distribuzione geografica
Continente #
AS - Asia 112
EU - Europa 40
NA - Nord America 40
SA - Sud America 27
AF - Africa 2
Totale 221
Nazione #
SG - Singapore 43
US - Stati Uniti d'America 39
BR - Brasile 20
CN - Cina 17
HK - Hong Kong 17
VN - Vietnam 14
DE - Germania 13
KR - Corea 12
IT - Italia 7
AR - Argentina 5
FR - Francia 4
NL - Olanda 4
RU - Federazione Russa 3
AT - Austria 2
GB - Regno Unito 2
IQ - Iraq 2
SE - Svezia 2
BD - Bangladesh 1
EC - Ecuador 1
EG - Egitto 1
ES - Italia 1
FI - Finlandia 1
ID - Indonesia 1
IN - India 1
JP - Giappone 1
LB - Libano 1
MN - Mongolia 1
MX - Messico 1
PL - Polonia 1
PY - Paraguay 1
SO - Somalia 1
TR - Turchia 1
Totale 221
Città #
Singapore 24
Hong Kong 17
Seoul 12
Munich 9
Ashburn 8
Piscataway 6
Boardman 5
Ho Chi Minh City 5
Hefei 4
Beijing 3
Frankfurt am Main 3
Hanoi 3
Amsterdam 2
Atlanta 2
Los Angeles 2
Santa Clara 2
Stockholm 2
São Paulo 2
Amelia 1
Angra dos Reis 1
Ankara 1
Aprilia 1
Asunción 1
Bastia umbra 1
Bexley 1
Bosaso 1
Bragança Paulista 1
Bắc Ninh 1
Campo Belo 1
Catanduva 1
Chennai 1
Chicago 1
Cidreira 1
Dallas 1
Dhaka 1
Diadema 1
Falkenstein 1
Goiás 1
Guarulhos 1
Huế 1
Isidro Casanova 1
Jaguaruana 1
Mexico City 1
Moscow 1
New York 1
Ninh Bình 1
Orem 1
Phoenix 1
Port Said 1
Quevedo 1
Quận Bình Thạnh 1
Rembangan 1
Ribeirão Claro 1
Rondonópolis 1
Rosario 1
San Juan 1
San Miguel de Tucumán 1
Seattle 1
Sorocaba 1
Suzano 1
São Gonçalo 1
São Raimundo Nonato 1
The Dalles 1
Tokyo 1
Tuparetama 1
Turku 1
Ulan Bator 1
Uruguaiana 1
Vienna 1
Villa Regina 1
Votorantim 1
Warsaw 1
Wuhan 1
Totale 166
Nome #
Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer 54
Correction: Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer (Oncology and Therapy, (2024), 12, 1, (163-171), 10.1007/s40487-023-00251-6) 40
Navigating challenges in EGFR exon 20 insertions: The PAPILLON trial unravels the promise of amivantamab-chemotherapy 37
Non-small cell lung cancer: an update on emerging EGFR-targeted therapies 34
A prospective study on clinicians' attitudes and survival outcomes for patients with advanced NSCLC and poor performance status in the immunotherapy era: PICASO (GOIRC-04-2020) 32
A Podcast on Pre- or Perioperative Chemoimmunotherapy for Stage III Non-Small Cell Lung Cancer: Shared Agreement from the Thoracic Surgeon and Oncologist Perspectives 31
Totale 228
Categoria #
all - tutte 1.111
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.111


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202413 0 0 0 0 0 1 4 0 2 0 4 2
2024/202556 1 4 2 1 4 3 1 2 3 2 23 10
2025/2026159 17 37 20 46 34 5 0 0 0 0 0 0
Totale 228